Placental Vitamin D-Binding Protein Expression in Human Idiopathic Fetal Growth Restriction

Alice F. Wookey, Tejasvy Chollangi, Hannah Ee Juen Yong, Bill Kalionis, Shaun P. Brennecke, Padma Murthi, Harry M Georgiou

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

Vitamin D-binding protein is a multifunctional serum protein with multiple actions related to normal health. Vitamin D-binding protein transports vitamin D and influences the metabolism of this key hormone but it also has additional immunomodulatory and actin-clearing properties. We investigated whether vitamin D-binding protein expression is altered in fetal growth restriction-associated placental dysfunction. Protein was extracted from 35 placentae derived from 17 healthy control subjects and 18 gestation-matched subjects with fetal growth restriction (FGR). FGR subjects were further subdivided as idiopathic (n=9) and nonidiopathic (n=9). Vitamin D-binding protein and 25(OH) vitamin D were measured by ELISA and normalized to protein concentration. The results showed significantly reduced levels of placental vitamin D-binding protein (control versus FGR, p<0.05, Student's t-test) that were strongly associated with idiopathic fetal growth restriction (p<0.01, Kruskal-Wallis), whereas levels of vitamin D-binding protein were not associated with placental 25(OH) vitamin D stores (p=0.295, Pearson's correlation). As such, vitamin D-binding protein may be a factor in unexplained placental dysfunction associated with idiopathic fetal growth restriction and may potentially serve as a biomarker of this disease.

Original languageEnglish
Article number5120267
Number of pages5
JournalJournal of Pregnancy
Volume2017
DOIs
Publication statusPublished - 15 Feb 2017

Cite this